Register Login

Envoy Medical Inc (COCH)

(90% Positive) ENVOY MEDICAL, INC. (COCH) Announces Enrollment Update for changes Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Dec. 17, 2025, 4:43 a.m.

    📋 ENVOY MEDICAL, INC. (COCH) - Clinical Trial Update

    Filing Date: 2025-12-16

    Accepted: 2025-12-16 09:47:46

    Event Type: Clinical Trial Update

    Event Details:

    Envoy Medical Inc (COCH) Announces Clinical Trial Update Envoy Medical Inc (COCH) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: changes, outlook
    • Diseases/Conditions: such trials, its business
    • Clinical Stage: clinical trial
    • Collaboration: IRB
    • Updated Timeline: DECEMBER 2025
      • anticipated in approximately 24 months (end of 2027

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Envoy Medical Inc
    • CIK: 0001840877
    • Ticker Symbol: COCH
    • Period End Date: 2025-12-16
    • Document Type: 8-K

Search

News categories